Abstract. Building on the success of the many earlier studies on electrospun nanofibers technique which provide a non woven web to the order of nanometers introducing superior properties such as large surface area, superior mechanical properties and ease of implementation in many fields of applications, elctrospun nanofibers became an important issue for many researchers in various fields. Using elctrospun fibers as a drug carrier, is showing a huge promising potential for the future of biomedical application. Our work in this research is focusing on engineering a system to control the drug release profile rate especially for wound dressing. Nanocomposite multilayer fibrous membranes, using electrospinning method, have been developed for drug release in form of sandwich structure of three layers. Inner layer which is kept Polycaprolactane (PCL) loaded with drug. The two outer layers have been changed with different blend ratios between Chitosan (Cs) and PCL as follow [0%:100% Cs:PCL, 30%:70% Cs:PCL, 50%:50% Cs:PCL, 70%:30% Cs:PCL]. The results showed that the release rate has been affected dramatically by the outer layer composition. SEM images showed changing in the morphology due to the different in the composition of outer layer.
Introduction
Building on the success of the many earlier studies on electrospun nanofibers technique which provide a non woven web to the order of nanometers introducing superior properties such as large surface area, superior mechanical properties and ease of implementation in many fields of applications, elctrospun nanofibers became an important issue for many researchers in various fields. Using elctrospun fibers as a drug carrier, is showing a huge promising potential for the future of biomedical application, especially developing nontraditional wound dressing [1, 2, 3] . Our work in this research is focusing on engineering a system to control the drug release profile rate especially for wound dressing. Different wound types require different drug release rates Fig. 1 . So that controlling the rate of drug release attract the attention of many researchers [4] . Chitosan (β-(1-4)-linked D-glucosamine) is a natural polymer derived from deacetylation of Chitin (the 2 nd most abundant polymer after cellulose) existing in crust shells e.g. shrimp shell, crab shell and krill [5] . Chitosan has attractive attention in medical applications due to its antibacterial, antitumor, Hemostatic, Fungistatic, non-toxic, wound healing, biocompatible and biodegradable properties [6, 7, 8, 9, 10] . It has been used in various fields such as agriculture, waste treatment, cosmetics, food [11, 12, 13] .
Nanofibrous structures are promising materials for applications in medical sector such as tissue engineering, wound dressing, drug delivery, hygiene industry (napkins, wipers, absorbers), intelligent textiles (sensing, actuating) and for coatings (multifunctional coatings) [14, 15, 16] .
The formation of nanofiber with diameters being in sub-micrometer to several nanometer depending on the polymer and processing conditions specially for treatment of dermal wounds caused by fire, heat, chemicals, ultraviolet, electricity or disease [17] . Due to medical properties of chitosan, it has attracted significant properties in nanofiber fabrication for cell and tissue engineering [18, 19] .
Our work in this research is focusing on engineering a system to control the drug release profile rate, especially for wound dressing. Nanocomposite multilayer fibrous membranes, using electrospinning method, have been developed for drug release in form of sandwich structure of three layers Fig. 2 . Inner layer was kept Polycaprolactane (PCL) loaded with drug. The two outer layers have been changed with different blend ratios between Chitosan (Cs) and PCL as follow [0%:100% Cs:PCL, 30%:70% Cs:PCL, 50%:50% Cs:PCL, 70%:30% Cs:PCL].
Fig. 2 Multilayer sandwich structure

Materials and Method
Chitosan from shrimp shell was prepared in our labs (M v =600-750 KDa ) determined by MarkHouwink equation. the degree of deacetylation (DD) was 87%, The DD was measured by FTIR spectrophotometer method , Polycaprolacton (PCL) (M n =70-90 KDa ) purchased from SigmaAldrich , Acetic acid (AA) (≥99.98%) purchased from Sigma-Aldrich, Trifluoroacetic acid (TFA) purchased from SDFCL India, Formic acid(FA) (98/100%)purchased from Fisher Scientific, Sodium dihydrogen phosphate dihydrate purchased from Sigma-Aldrich, Sodium phosphate dibasic dihydrate purchased from Sigma-Aldrich, Ciprofloxacine HCL given From Pharco company, Egypt.
Electrospinning
For the two outer layers, solution of 3% chitosan (w/v) has prepared using Trifluoroacetic acid (TFA). The solution was prepared under magnetic stirrer at room temperature and was kept overnight to ensure completely dissolving. Polycaprolactone (PCL) solution has been dissolved in TFA with 10 % (w/v) under magnetic stirrer at room temperature till complete dissolving of PCL. Blended solutions from theses two previous solutions were prepared as follow 30:70, 50:50, 70:30
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(wt/wt) chitosan/PCL respectively. On the other hand, PCL was dissolved using AA/FA (70:30) and then 10% of ciprofloxacin HCL has been added. This solution was used for the inner layer for all experiments. NANON electospinning machine has been used for producing nanofiber. The samples were collected on a ground plat collector. The outer two layer Cs/PCL solutions were electrospun at the following conditions: voltage: 28 KV, Feed rate: 0.9ml/hr and the distance between nozzle and collector: 13 cm. The inert layer PCL-CiprofloxacinHCL was electrospun at 25 KV applied voltage, 15 cm needle to collector distance and 1ml/hr extrusion rate. All electrospinning were carried out at room temperature.
Characterization
The Multi-layer system has been characterized by SEM (JEOL JSM-6010LV) for morphology, UVSpectrophotometer (Hitachi U-3900 spectrophotometer) for studying the behavior of the drug release profile.
Results and Discussion
SEM micrograph of every layer separately is shown in Fig. 3 are made from Cs/PCL in (30:70, 50:50, 70:30) respectively and Fig. 4 are the cross sectional images of the triple layers consists of (Cs-PCl/PCL-Cipro/Cs-PCL) has Different ratios in the outer layer of Chitosan and PCL (70:30, 50:50, 30:70, 0:100). The SEM images showed that all solutions has been produced excellent fiber morphology in nanoscale which indicates the success of producing nanofiber from all blends of chitosan/PCL even with high chitosan content. Also the images of the cross section of the multilayer system showed a good adhesion between the layer and no separation. To investigate the difference between the multilayer system (sandwich structure) and the blending system, a sample with composition of Cs:PCL(50:50) loaded by Ciprofluxacin.HCl was produced as a monolayer. The monolayer blended sample compared to multilayer structure of Cs:PCL(50:50) as outer two layers and PCL contain Cipro 10% as inner layer. Fig. 6 shows the drug release profile rate of the two system monolayer blended and multi layer. The results indicate that by the sandwich technique, the drug can be sustained for a long period. Fig. 6 Comparison between the monolayer blend and multilayer structure.
Conclusion:
A multilayer system has been developed to control the drug release profile rate according the need. Different compositions of the outer layers have been produced to control the release of drug. It was very clear that by increasing the hydrophopicity of the outer layer, the release rate is slowing down. The comparison between the monolayer and multi layer system has indicated the multilayer system can maintain the drug much more time than the monolayer. The previous results, it can be concluded that the drug release can be controlled as needed (Different wound types require different drug release rates). This can be achieved by engineering the carrier and outer layer in regarding to its thickness and hydrophilcilty.
